198 related articles for article (PubMed ID: 33222332)
1. NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK-NRF2 signaling.
Yang Y; Zheng J; Wang M; Zhang J; Tian T; Wang Z; Yuan S; Liu L; Zhu P; Gu F; Fu S; Shan Y; Pan Z; Zhou W
Cancer Sci; 2021 Feb; 112(2):641-654. PubMed ID: 33222332
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma.
Shimokawa M; Yoshizumi T; Itoh S; Iseda N; Sakata K; Yugawa K; Toshima T; Harada N; Ikegami T; Mori M
Cancer Sci; 2020 Apr; 111(4):1228-1240. PubMed ID: 31968140
[TBL] [Abstract][Full Text] [Related]
3. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H: Quinone oxidoreductase 1 overexpression in hepatocellular carcinoma potentiates apoptosis evasion through regulating stabilization of X-linked inhibitor of apoptosis protein.
Li WY; Zhou HZ; Chen Y; Cai XF; Tang H; Ren JH; Wai Wong VK; Kwan Law BY; Chen Y; Cheng ST; Yu HB; Cai HY; Chen WX; Tang N; Zhang WL; Tao NN; Yang QX; Ren F; He L; Jiang H; Huang AL; Chen J
Cancer Lett; 2019 Jun; 451():156-167. PubMed ID: 30867140
[TBL] [Abstract][Full Text] [Related]
5. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
8. Overexpression of NAD(P)H: Quinone Oxidoreductase 1 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induced Apoptosis by Activating AMPK/PGC-1α Pathway.
Zhang X; Han K; Yuan DH; Meng CY
DNA Cell Biol; 2017 Apr; 36(4):256-263. PubMed ID: 28191864
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H Quinone Dehydrogenase 1 Ablation Inhibits Activation of the Phosphoinositide 3-Kinase/Akt Serine/Threonine Kinase and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathways and Blocks Metabolic Adaptation in Hepatocellular Carcinoma.
Dimri M; Humphries A; Laknaur A; Elattar S; Lee TJ; Sharma A; Kolhe R; Satyanarayana A
Hepatology; 2020 Feb; 71(2):549-568. PubMed ID: 31215069
[TBL] [Abstract][Full Text] [Related]
10. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma.
Lv X; Zhao F; Huo X; Tang W; Hu B; Gong X; Yang J; Shen Q; Qin W
Med Oncol; 2016 Jul; 33(7):70. PubMed ID: 27262566
[TBL] [Abstract][Full Text] [Related]
12. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
[TBL] [Abstract][Full Text] [Related]
13. DEAD-box Helicase 27 Promotes Hepatocellular Carcinoma Progression Through ERK Signaling.
Xiaoqian W; Bing Z; Yangwei L; Yafei Z; Tingting Z; Yi W; Qingjun L; Suxia L; Ling Z; Bo W; Peng Z
Technol Cancer Res Treat; 2021; 20():15330338211055953. PubMed ID: 34855554
[No Abstract] [Full Text] [Related]
14. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
Huang S; Li J; Tam NL; Sun C; Hou Y; Hughes B; Wang Z; Zhou Q; He X; Wu L
Mol Carcinog; 2019 Apr; 58(4):603-615. PubMed ID: 30556610
[TBL] [Abstract][Full Text] [Related]
15. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
16. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
17. NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma.
Zhou HZ; Zeng HQ; Yuan D; Ren JH; Cheng ST; Yu HB; Ren F; Wang Q; Qin YP; Huang AL; Chen J
Cell Commun Signal; 2019 Dec; 17(1):168. PubMed ID: 31842909
[TBL] [Abstract][Full Text] [Related]
18. Modulation of YrdC promotes hepatocellular carcinoma progression via MEK/ERK signaling pathway.
Huang S; Zhu P; Sun B; Guo J; Zhou H; Shu Y; Li Q
Biomed Pharmacother; 2019 Jun; 114():108859. PubMed ID: 30978526
[TBL] [Abstract][Full Text] [Related]
19. EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics.
Zhong FJ; Li YM; Xu C; Sun B; Wang JL; Yang LY
Clin Sci (Lond); 2021 Apr; 135(7):847-864. PubMed ID: 33755094
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor E2-related factor 2-mediated induction of NAD(P)H:quinone oxidoreductase 1 by 3,5-dimethoxy-trans-stilbene.
Park EJ; Min HY; Park HJ; Chung HJ; Ahn YH; Pyee JH; Lee SK
J Pharmacol Sci; 2011; 116(1):89-96. PubMed ID: 21512304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
